← Back to Search

Treatment for Biliary Atresia (PROBE Trial)

N/A
Recruiting
Led By Robert Merion, MD
Research Sponsored by Arbor Research Collaborative for Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at baseline, 1month, 2 months, 3, 6 months post-baseline, 12 and 18 months of age, then annually through year 15.
Awards & highlights

Summary

Biliary atresia, idiopathic neonatal hepatitis, and specific genetic cholestatic conditions are the most common causes of jaundice and hyperbilirubinemia that continue beyond the newborn period. The long term goal of the Childhood Liver Disease Research Network (ChiLDReN) is to establish a database of clinical information and plasma, serum, and tissue samples from cholestatic children to facilitate research and to perform clinical, epidemiological and therapeutic trials in these important pediatric liver diseases.

Eligible Conditions
  • Biliary Atresia
  • Neonatal Cholestasis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at baseline, 1month, 2 months, 3, 6 months post-baseline, 12 and 18 months of age, then annually through year 15.
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at baseline, 1month, 2 months, 3, 6 months post-baseline, 12 and 18 months of age, then annually through year 15. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in disease severity over time (disease progression)

Find a Location

Who is running the clinical trial?

Arbor Research Collaborative for HealthLead Sponsor
20 Previous Clinical Trials
34,467 Total Patients Enrolled
2 Trials studying Biliary Atresia
1,817 Patients Enrolled for Biliary Atresia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,410 Previous Clinical Trials
4,323,891 Total Patients Enrolled
5 Trials studying Biliary Atresia
3,088 Patients Enrolled for Biliary Atresia
Robert Merion, MDPrincipal InvestigatorArbor Research Collaborative of Health
3 Previous Clinical Trials
3,227 Total Patients Enrolled
1 Trials studying Biliary Atresia
552 Patients Enrolled for Biliary Atresia
~183 spots leftby May 2029
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top